Recent advancements in immunotherapy and targeted therapies are providing new hope in the fight against cancer, with exciting breakthroughs in treatments for various tumor types.

Vaccines are now being developed that can potentially cure cancers by using personalized proteins from a patient's tumor, which are currently in clinical trials.

Personalized medicine, which tailors treatment plans to individual patients based on their specific medical cases, is on the horizon and could significantly improve life expectancy.

We can significantly impact cancer prevention using polygenic risk scores and multi-cancer early detection tests that identify microscopic cancer.

Erasca's mission is to erase cancer, specifically targeting RAS-driven cancers, and while we are making progress, we still have a long way to go.

Recent advances in immunotherapy have led to unprecedented cures for autoimmune diseases, demonstrating our growing ability to control the immune system.

Cancer rates are rising due to metabolic crises linked to obesity. Many cancers, such as colon and breast cancer, are driven by insulin resistance, which can be mitigated by reducing carbohydrate intake and increasing healthy fats.

The treatment plan involved a year of intensive chemotherapy followed by three years of less intense treatment, which was a challenging journey for me.

The future holds the potential to eradicate diseases, with nonprofits working to identify all human druggable targets to aid the drug industry.